Brucellar spondylitis: a detailed analysis based on current findings

J Ariza, F Gudiol, J Valverde, R Pallares… - Reviews of infectious …, 1985 - academic.oup.com
Three hundred thirty-one cases of brucellosis included in a 10-year prospective protocol
were reviewed to identify and follow up patients with spondylitis. Of 20 patients (17 male and …

[HTML][HTML] Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain

…, PF Viladrich, R Martin, F Gudiol - … England Journal of …, 1995 - Mass Medical Soc
Background Penicillin-resistant strains of Streptococcus pneumoniae are now found
worldwide, and strains with resistance to cephalosporin are being reported. The appropriate …

[HTML][HTML] Management of methicillin-resistant Staphylococcus aureus infections

J Garau, E Bouza, J Chastre, F Gudiol… - Clinical microbiology and …, 2009 - Elsevier
This review addresses selected aspects of the management of severe healthcare-associated
infections due to methicillin-resistant Staphylococcus aureus (MRSA), including the …

Beta-lactam antibiotics

C Suarez, F Gudiol - Enfermedades infecciosas y microbiologia …, 2009 - europepmc.org
Beta-lactam drugs, whose mechanism of action is inhibition of the last stage of bacterial cell
wall synthesis, are the largest family of antimicrobial agents and the most widely used in …

Emergence and Rapid Spread of Carbapenem Resistance during a Large and Sustained Hospital Outbreak of MultiresistantAcinetobacter baumannii

…, F Garrigosa, J Ariza, F Gudiol - Journal of clinical …, 2000 - Am Soc Microbiol
Beginning in 1992, a sustained outbreak of multiresistantAcinetobacter baumannii infections
was noted in our 1,000-bed hospital in Barcelona, Spain, resulting in considerable overuse …

[HTML][HTML] A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease

…, JM Leonard, LM Lehman, F Gudiol… - … England Journal of …, 1995 - Mass Medical Soc
Background Reverse-transcriptase inhibitors have only moderate clinical efficacy against
the human immunodeficiency virus type 1 (HIV-1). Ritonavir is an inhibitor of HIV-1 protease …

Health care–associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes

…, R Verdaguer, F Manresa, F Gudiol - Archives of internal …, 2007 - jamanetwork.com
Background Health care–associated pneumonia (HCAP) has been proposed as a new
category of respiratory infection. However, limited data exist to validate this entity. We aimed to …

Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases

…, R Pallares, J Liñares, J Ariza, F Gudiol - Antimicrobial agents …, 1998 - Am Soc Microbiol
An outbreak due to extended-spectrum β-lactamase-producingKlebsiella pneumoniae (ESBL-KP)
was detected from May 1993 to June 1995. A total of 145 patients, particularly patients …

Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia

…, F Tubau, F Manresa, F Gudiol - Archives of internal …, 2004 - jamanetwork.com
Background Early failure is a matter of great concern in the treatment of community-acquired
pneumonia. However, information on its causes and risk factors is lacking. Methods …

Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes

…, B Rosón, J Dorca, R Verdaguer, F Manresa, F Gudiol - Medicine, 2003 - journals.lww.com
We performed an observational analysis of pro-spectively collected data on 1,474 adult
patients who were hospitalized for community-acquired pneumonia; 1,169 patients were under …